BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Berends MJ, Hollema H, Wu Y, van Der Sluis T, Mensink RG, ten Hoor KA, Sijmons RH, de Vries EG, Pras E, Mourits MJ, Hofstra RM, Buys CH, Kleibeuker JH, van Der Zee AG. MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer. Int J Cancer 2001;92:398-403. [PMID: 11291077 DOI: 10.1002/ijc.1206] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Canet-Hermida J, Marín F, Dorca E, Dueñas N, Costa L, Salinas M, Velasco À, Peremiquel-Trillas P, Paytubi S, Ponce J, Fernández S, Martínez JM, Cárdenas L, Taltavull A, Alemany L, Meléndez C, Oliveras G, Vidal A, Capellá G, López-Bonet E, Brunet J, Matias-Guiu X, Pineda M. Highly Sensitive Microsatellite Instability and Immunohistochemistry Assessment in Endometrial Aspirates as a Tool for Cancer Risk Individualization in Lynch Syndrome. Mod Pathol 2023;:100158. [PMID: 36918055 DOI: 10.1016/j.modpat.2023.100158] [Reference Citation Analysis]
2 Nolano A, Medugno A, Trombetti S, Liccardo R, De Rosa M, Izzo P, Duraturo F. Hereditary Colorectal Cancer: State of the Art in Lynch Syndrome. Cancers (Basel) 2022;15. [PMID: 36612072 DOI: 10.3390/cancers15010075] [Reference Citation Analysis]
3 Zhao F, Dong D, Du H, Guo Y, Su X, Wang Z, Xie X, Wang M, Zhang H, Cao X, He X. Diagnosis of endometrium hyperplasia and screening of endometrial intraepithelial neoplasia in histopathological images using a global-to-local multi-scale convolutional neural network. Computer Methods and Programs in Biomedicine 2022;221:106906. [DOI: 10.1016/j.cmpb.2022.106906] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Huang M, Hunter T, Fein LA, Galli J, George S, Schlumbrecht M, McCarter K, Sinno AK, Guido LP, Pinto A. Lost opportunities for mismatch repair (MMR) screening among minority women with endometrial cancer. Sci Rep 2021;11:11712. [PMID: 34083606 DOI: 10.1038/s41598-021-91053-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Euscher ED, Buza N, Hui P. Immunohistochemistry. Practical Gynecologic Pathology 2021. [DOI: 10.1007/978-3-030-68608-6_15] [Reference Citation Analysis]
6 Wong S, Hui P, Buza N. Frequent loss of mutation-specific mismatch repair protein expression in nonneoplastic endometrium of Lynch syndrome patients. Mod Pathol 2020;33:1172-81. [PMID: 31932681 DOI: 10.1038/s41379-020-0455-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
7 Missaoui N, Boukhari N, Limam S, Hmissa S, Mokni M. Utility of the immunohistochemical analysis of DNA mismatch-repair proteins in endometrial hyperplasia. Acta Histochem 2020;122:151505. [PMID: 31955910 DOI: 10.1016/j.acthis.2020.151505] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Lucas E, Chen H, Molberg K, Castrillon DH, Rivera Colon G, Li L, Hinson S, Thibodeaux J, Lea J, Miller DS, Zheng W. Mismatch Repair Protein Expression in Endometrioid Intraepithelial Neoplasia/Atypical Hyperplasia: Should We Screen for Lynch Syndrome in Precancerous Lesions? Int J Gynecol Pathol 2019;38:533-42. [PMID: 30383610 DOI: 10.1097/PGP.0000000000000557] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
9 Sugiyama Y, Gotoh O, Fukui N, Tanaka N, Hasumi K, Takazawa Y, Noda T, Mori S. Two Distinct Tumorigenic Processes in Endometrial Endometrioid Adenocarcinoma. The American Journal of Pathology 2020;190:234-51. [DOI: 10.1016/j.ajpath.2019.09.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
10 Bartosch C, Clarke B, Bosse T. Gynaecological neoplasms in common familial syndromes (Lynch and HBOC). Pathology 2018;50:222-37. [PMID: 29287922 DOI: 10.1016/j.pathol.2017.10.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
11 Sanderson PA, Critchley HO, Williams AR, Arends MJ, Saunders PT. New concepts for an old problem: the diagnosis of endometrial hyperplasia. Hum Reprod Update 2017;23:232-54. [PMID: 27920066 DOI: 10.1093/humupd/dmw042] [Cited by in Crossref: 57] [Cited by in F6Publishing: 84] [Article Influence: 9.5] [Reference Citation Analysis]
12 Vierkoetter KR, Kagami LA, Ahn HJ, Shimizu DM, Terada KY. Loss of Mismatch Repair Protein Expression in Unselected Endometrial Adenocarcinoma Precursor Lesions. Int J Gynecol Cancer 2016;26:228-32. [PMID: 26807560 DOI: 10.1097/IGC.0000000000000606] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
13 Bartosch C, Pires-luís AS, Meireles C, Baptista M, Gouveia A, Pinto C, Shannon KM, Jerónimo C, Teixeira MR, Lopes JM, Oliva E. Pathologic Findings in Prophylactic and Nonprophylactic Hysterectomy Specimens of Patients With Lynch Syndrome. American Journal of Surgical Pathology 2016;40:1177-91. [DOI: 10.1097/pas.0000000000000684] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
14 Moreno-Ortiz JM, Ayala-Madrigal Mde L, Corona-Rivera JR, Centeno-Flores M, Maciel-Gutiérrez V, Franco-Topete RA, Armendáriz-Borunda J, Hotchkiss E, Pérez-Carbonell L, Rhees J, Boland CR, Gutiérrez-Angulo M. Novel Mutations in MLH1 and MSH2 Genes in Mexican Patients with Lynch Syndrome. Gastroenterol Res Pract 2016;2016:5278024. [PMID: 27247567 DOI: 10.1155/2016/5278024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
15 Němejcová K, Kenny SL, Laco J, Škapa P, Staněk L, Zikán M, Kleiblová P, Mccluggage WG, Dundr P. Atypical Polypoid Adenomyoma of the Uterus: An Immunohistochemical and Molecular Study of 21 Cases. American Journal of Surgical Pathology 2015;39:1148-55. [DOI: 10.1097/pas.0000000000000428] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
16 Aguirre E, Graña B, Boudet M, Balmaña J. Screening for Lynch syndrome among patients with newly diagnosed endometrial cancer: a comprehensive review. Tumori 2016;102:548-54. [PMID: 26219573 DOI: 10.5301/tj.5000385] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Huang M, Djordjevic B, Yates MS, Urbauer D, Sun C, Burzawa J, Daniels M, Westin SN, Broaddus R, Lu K. Molecular pathogenesis of endometrial cancers in patients with Lynch syndrome. Cancer. 2013;119:3027-3033. [PMID: 23760948 DOI: 10.1002/cncr.28152] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
18 Karamurzin Y, Soslow RA, Garg K. Histologic evaluation of prophylactic hysterectomy and oophorectomy in Lynch syndrome. Am J Surg Pathol. 2013;37:579-585. [PMID: 23426126 DOI: 10.1097/pas.0b013e3182796e27] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
19 Zahary MN, Kaur G, Abu Hassan MR, Singh H, Naik VR, Ankathil R. Germline mutation analysis of MLH1 and MSH2 in Malaysian Lynch syndrome patients. World J Gastroenterol 2012; 18(8): 814-820 [PMID: 22371642 DOI: 10.3748/wjg.v18.i8.814] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
20 Giaginis C, Michailidi C, Stolakis V, Alexandrou P, Tsourouflis G, Klijanienko J, Delladetsima I, Theocharis S. Expression of DNA repair proteins MSH2, MLH1 and MGMT in human benign and malignant thyroid lesions: an immunohistochemical study. Med Sci Monit 2011;17:BR81-90. [PMID: 21358597 DOI: 10.12659/msm.881444] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
21 Weissman SM, Bellcross C, Bittner CC, Freivogel ME, Haidle JL, Kaurah P, Leininger A, Palaniappan S, Steenblock K, Vu TM, Daniels MS. Genetic counseling considerations in the evaluation of families for Lynch syndrome--a review. J Genet Couns 2011;20:5-19. [PMID: 20931355 DOI: 10.1007/s10897-010-9325-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
22 Ferreira AM, Westers H, Wu Y, Niessen RC, Olderode-Berends M, van der Sluis T, van der Zee AG, Hollema H, Kleibeuker JH, Sijmons RH, Hofstra RM. Do microsatellite instability profiles really differ between colorectal and endometrial tumors? Genes Chromosomes Cancer 2009;48:552-7. [PMID: 19373783 DOI: 10.1002/gcc.20664] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
23 Karamurzin Y, Rutgers JK. DNA mismatch repair deficiency in endometrial carcinoma. Int J Gynecol Pathol 2009;28:239-55. [PMID: 19620942 DOI: 10.1097/PGP.0b013e31818d8fe6] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 3.9] [Reference Citation Analysis]
24 Rubinstein WS, Weissman SM. Managing hereditary gastrointestinal cancer syndromes: the partnership between genetic counselors and gastroenterologists. Nat Clin Pract Gastroenterol Hepatol. 2008;5:569-582. [PMID: 18797444 DOI: 10.1038/ncpgasthep1235] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
25 Allison KH, Tenpenny E, Reed SD, Swisher EM, Garica RL. Immunohistochemical markers in endometrial hyperplasia: is there a panel with promise? A review. Appl Immunohistochem Mol Morphol 2008;16:329-43. [PMID: 18528284 DOI: 10.1097/PAI.0b013e318159b88e] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
26 Linkov F, Yurkovetsky Z, Taioli E, Havrilesky LJ, Maxwell GL, Lokshin A. Endometrial cancer: multiplexed Luminex approaches for early detection. Expert Opinion on Medical Diagnostics 2008;2:527-37. [DOI: 10.1517/17530059.2.5.527] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
27 Soliman PT, Lu K. Endometrial cancer associated with defective DNA mismatch repair. Obstet Gynecol Clin North Am 2007;34:701-15, viii. [PMID: 18061865 DOI: 10.1016/j.ogc.2007.09.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
28 Nijhuis ER, Nijman HW, Oien KA, Bell A, ten Hoor KA, Reesink-Peters N, Boezen HM, Hollema H, van der Zee AG. Loss of MSH2 protein expression is a risk factor in early stage cervical cancer. J Clin Pathol 2007;60:824-30. [PMID: 17596548 DOI: 10.1136/jcp.2005.036038] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
29 Hewitt MJ, Wood N, Quinton ND, Charlton R, Taylor G, Sheridan E, Duffy SR. The detection of microsatellite instability in blind endometrial samples--a potential novel screening tool for endometrial cancer in women from hereditary nonpolyposis colorectal cancer families? Int J Gynecol Cancer 2006;16:1393-400. [PMID: 16803536 DOI: 10.1111/j.1525-1438.2006.00604.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
30 Xiao GZ, Liu XS. Expression of DNA mismatch repair gene hMLH1 and its significance in gastric cancer and premalignant lesions. Shijie Huaren Xiaohua Zazhi 2006; 14(21): 2093-2097 [DOI: 10.11569/wcjd.v14.i21.2093] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
31 Olschwang S, Bonaïti-Pellié C, Feingold J, Frébourg T, Grandjouan S, Lasset C, Laurent-Puig P, Lecuru F, Millat B, Sobol H, Thomas G, Eisinger F. [Identification and management of HNPCC syndrome (hereditary non polyposis colon cancer), hereditary predisposition to colorectal and endometrial adenocarcinomas]. Pathol Biol (Paris) 2006;54:215-29. [PMID: 16677780 DOI: 10.1016/j.patbio.2006.02.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
32 Olschwang S, Eisinger F. Prédisposition héréditaire au cancer colorectal et inactivation de la fonction de réparation des mésappariements de l'ADN. EMC - Gastro-entérologie 2006;1:1-6. [DOI: 10.1016/s1155-1968(05)38974-7] [Reference Citation Analysis]
33 Lu KH, Broaddus RR. Gynecologic Cancers in Lynch Syndrome/HNPCC. Fam Cancer 2005;4:249-54. [PMID: 16136386 DOI: 10.1007/s10689-005-1838-3] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
34 Olschwang S, Eisinger F. Prédisposition héréditaire au cancer colorectal et inactivation de la fonction de réparation des mésappariements de l'ADN. EMC - Hépato-Gastroenterologie 2005;2:214-22. [DOI: 10.1016/j.emchg.2005.03.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Ollikainen M, Abdel-Rahman WM, Moisio AL, Lindroos A, Kariola R, Järvelä I, Pöyhönen M, Butzow R, Peltomäki P. Molecular analysis of familial endometrial carcinoma: a manifestation of hereditary nonpolyposis colorectal cancer or a separate syndrome? J Clin Oncol. 2005;23:4609-4616. [PMID: 15837969 DOI: 10.1200/JCO.2005.06.055] [Cited by in Crossref: 101] [Cited by in F6Publishing: 107] [Article Influence: 5.6] [Reference Citation Analysis]
36 Kouraklis G, Misiakos EP. Hereditary nonpolyposis colorectal cancer (Lynch syndrome): criteria for identification and management. Dig Dis Sci 2005;50:336-44. [PMID: 15745097 DOI: 10.1007/s10620-005-1607-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
37 Bandera C. Endometrial Cancer in the Hereditary Nonpolyposis Colorectal Cancer Syndrome. Cancer of the Uterus 2004. [DOI: 10.1201/b14149-3] [Reference Citation Analysis]
38 Gallinger S, Aronson M, Shayan K, Ratcliffe EM, Gerstle JT, Parkin PC, Rothenmund H, Croitoru M, Baumann E, Durie PR, Weksberg R, Pollett A, Riddell RH, Ngan BY, Cutz E, Lagarde AE, Chan HS. Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. Gastroenterology 2004;126:576-85. [PMID: 14762794 DOI: 10.1053/j.gastro.2003.11.008] [Cited by in Crossref: 94] [Cited by in F6Publishing: 102] [Article Influence: 4.9] [Reference Citation Analysis]
39 Sutter C, Dallenbach-hellweg G, Schmidt D, Baehring J, Bielau S, von Knebel Doeberitz M, Gebert J. Molecular Analysis of Endometrial Hyperplasia in HNPCC-suspicious Patients May Predict Progression to Endometrial Carcinoma: . International Journal of Gynecological Pathology 2004;23:18-25. [DOI: 10.1097/01.pgp.0000101085.35393.4a] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
40 Berends MJ, Wu Y, Sijmons RH, van der Sluis T, Ek WB, Ligtenberg MJ, Arts NJ, ten Hoor KA, Kleibeuker JH, de Vries EG, Mourits MJ, Hollema H, Buys CH, Hofstra RM, van der Zee AG. Toward New Strategies to Select Young Endometrial Cancer Patients for Mismatch Repair Gene Mutation Analysis. JCO 2003;21:4364-70. [DOI: 10.1200/jco.2003.04.094] [Cited by in Crossref: 100] [Cited by in F6Publishing: 108] [Article Influence: 5.0] [Reference Citation Analysis]
41 Rijcken FE, van der Sluis T, Hollema H, Kleibeuker JH. Hyperplastic polyps in hereditary nonpolyposis colorectal cancer. Am J Gastroenterol 2003;98:2306-11. [PMID: 14572584 DOI: 10.1111/j.1572-0241.2003.07629.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
42 Drake AC, Campbell H, Porteous ME, Dunlop MG. The contribution of DNA mismatch repair gene defects to the burden of gynecological cancer. Int J Gynecol Cancer 2003;13:262-77. [PMID: 12801255 DOI: 10.1046/j.1525-1438.2003.13194.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
43 Järvinen HJ. Genetic testing for polyposis: practical and ethical aspects. Gut 2003;52 Suppl 2:ii19-22. [PMID: 12651878 DOI: 10.1136/gut.52.suppl_2.ii19] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
44 Grady WM. Genetic testing for high-risk colon cancer patients. Gastroenterology 2003;124:1574-94. [PMID: 12761718 DOI: 10.1016/s0016-5085(03)00376-7] [Cited by in Crossref: 137] [Cited by in F6Publishing: 143] [Article Influence: 6.9] [Reference Citation Analysis]
45 Maruyama A, Saito T, Hachitanda Y, Tsukamoto N. Cancer history and loss of MSH2 and MLH1 protein expression in patients with endometrial hyperplasia. Int J Gynecol Cancer 2003;13:352-60. [PMID: 12801268 DOI: 10.1046/j.1525-1438.2003.13190.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
46 Orbo A, Nilsen MN, Arnes MS, Pettersen I, Larsen K. Loss of expression of MLH1, MSH2, MSH6, and PTEN related to endometrial cancer in 68 patients with endometrial hyperplasia. Int J Gynecol Pathol 2003;22:141-8. [PMID: 12649668 DOI: 10.1097/00004347-200304000-00005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 1.7] [Reference Citation Analysis]
47 Fang DC, Yang SM, Yang JM, Liu HF, Peng GY, Xiao TL, Wang RQ, Liu WW. Methylation of hMLH1 and hMSH2 promoter in colorectal cancer with microsatellite instability. Shijie Huaren Xiaohua Zazhi 2003; 11(3): 302-305 [DOI: 10.11569/wcjd.v11.i3.302] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Peltomäki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol 2003;21:1174-9. [PMID: 12637487 DOI: 10.1200/JCO.2003.04.060] [Cited by in Crossref: 508] [Cited by in F6Publishing: 542] [Article Influence: 25.4] [Reference Citation Analysis]
49 Popnikolov NK, Gatalica Z, Colome-Grimmer MI, Sánchez RL. Loss of mismatch repair proteins in sebaceous gland tumors. J Cutan Pathol 2003;30:178-84. [PMID: 12641777 DOI: 10.1034/j.1600-0560.2003.00010.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 2.1] [Reference Citation Analysis]
50 Jagadeesh D, Syngal S. Genetic testing for hereditary nonpolyposis colorectal cancer. Curr Opin Gastroenterol 2003;19:57-63. [PMID: 15699895 DOI: 10.1097/00001574-200301000-00010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
51 Latta E, Chapman WB. PTEN mutations and evolving concepts in endometrial neoplasia: . Current Opinion in Obstetrics and Gynecology 2002;14:59-65. [DOI: 10.1097/00001703-200202000-00010] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 2.1] [Reference Citation Analysis]
52 Berends MJ, Wu Y, Sijmons RH, Mensink RG, van der Sluis T, Hordijk-Hos JM, de Vries EG, Hollema H, Karrenbeld A, Buys CH, van der Zee AG, Hofstra RM, Kleibeuker JH. Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant. Am J Hum Genet 2002;70:26-37. [PMID: 11709755 DOI: 10.1086/337944] [Cited by in Crossref: 218] [Cited by in F6Publishing: 228] [Article Influence: 10.4] [Reference Citation Analysis]
53 Lynch HT, Casey MJ, Knezetic JA, Shaw TG, Lynch JE, Bewtra C. Hereditary Factors in Endometrial Cancer. In: Giordano A, Bovicelli A, Kurman RJ, editors. Molecular Pathology of Gynecologic Cancer. Totowa: Humana Press; 2007. pp. 195-216. [DOI: 10.1007/978-1-59745-346-2_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]